Literature DB >> 17652536

Nuclear expression of STAT5 in intraductal papillary mucinous neoplasms of the pancreas.

Tatsuki R Kataoka1, Tatsuya Ioka, Yoshitane Tsukamoto, Makiko Matsumura, Shingo Ishiguro, Yasuko Nishizawa.   

Abstract

Intraductal papillary mucinous neoplasms (IPMNs) are noninvasive lesions of the pancreas and classified as intraductal papillary mucinous adenomas (IPMAs), borderline IPMNs, and intraductal papillary mucinous carcinomas (IPMCs). Expression patterns of the specific genes alter during IPMN progression. Based on the evidence that signal transducers and activators of transcription (STAT) 5 play important roles in tumor development, we tested STAT5 expression in IPMAs, borderline IPMNs, and IPMCs by immunohistochemical method. STAT5 frequently expressed in the nuclei of tumor cells of borderline IPMNs or IPMCs but was not observed in those of IPMAs. Nuclear expression of STAT5 protein correlated to the Ki-67 labeling index of the examined IPMNs. STAT5 protein could contribute to the progression and proliferation of IPMNs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652536     DOI: 10.1177/1066896907302233

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  4 in total

1.  STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases.

Authors:  Christian Moser; Petra Ruemmele; Sebastian Gehmert; Hedwig Schenk; Marina P Kreutz; Maria E Mycielska; Christina Hackl; Alexander Kroemer; Andreas A Schnitzbauer; Oliver Stoeltzing; Hans J Schlitt; Edward K Geissler; Sven A Lang
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

2.  MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm.

Authors:  Tatsuo Shimura; Yasuhide Kofunato; Ryo Okada; Rei Yashima; Koji Okada; Kenichiro Araki; Yasuo Hosouchi; Hiroyuki Kuwano; Seiichi Takenoshita
Journal:  Mol Clin Oncol       Date:  2016-05-20

3.  PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells.

Authors:  W Chien; K L Lee; L W Ding; P Wuensche; H Kato; N B Doan; L Poellinger; J W Said; H P Koeffler
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

4.  Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.

Authors:  Hiroki Sumiyoshi; Akira Matsushita; Yoshiharu Nakamura; Yoko Matsuda; Toshiyuki Ishiwata; Zenya Naito; Eiji Uchida
Journal:  Oncol Rep       Date:  2016-04-01       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.